Kimyrsa Coupon & Prices

Your monthly Kimyrsa cost savings if eligible

If you are eligible to receive your Kimyrsa prescription through the patient assistance program, your medication will be free. We charge a flat monthly service fee of $49 per medication to cover the cost of our services.

Am I eligible for Kimyrsa patient assistance?

To be eligible for the Kimyrsa patient assistance program, you will need to meet specific eligibility criteria set by the pharmaceutical company. At NiceRx, we review each Kimyrsa enrollment application individually. The main factors considered are:

• I am a permanent, legal resident of the United States or Puerto Rico
• I am uninsured or my insurance doesn’t cover my medication
• I meet certain income eligibility requirements

How do I apply for the Kimyrsa patient assistance program?

Applying for the Kimyrsa patient assistance program through NiceRx is simple. Begin by completing the enrollment application on our website. We will ask for details about your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers that supply your medication. We may be able to help you access patient assistance for other medications as well as Kimyrsa, so please tell us about any medications that you have been prescribed.

If we determine that you may be eligible for Kimyrsa assistance, we will handle the full enrollment process on your behalf. We will work with your healthcare provider to prepare and submit all the documents required for you to enroll. If you are successfully enrolled in the Kimyrsa patient assistance program, we will also request your Kimyrsa medication refills on your behalf for up to 1 year. At the end of your enrollment period, we will contact you for updated details and seek to re-enroll you in the program.

Is NiceRx a Kimyrsa coupon provider?

NiceRx does not provide Kimyrsa coupons, discount cards or copay cards. We do not offer printable Kimyrsa manufacturer coupons, Kimyrsa discounts, rebates, Kimyrsa savings cards, trial offers, or free samples. We are a service provider that helps eligible individuals access patient assistance programs. Our service cost is $49 a month per medication, so you will likely save more on your Kimyrsa medication with NiceRx.

Can NiceRx help me get Kimyrsa cheaper if I have insurance?

NiceRx may be able to help you access Kimyrsa patient assistance if:

• You have a high copay or coinsurance responsibility for Kimyrsa
• Your insurance company will not pay for your Kimyrsa prescription
• You do not have insurance

Complete your enrollment application online to find out more.

How much does Kimyrsa cost without insurance?

Kimyrsa prices without insurance will vary by retailer. As a guide, Kimyrsa intravenous powder for injection 1200 mg will typically cost around $5,100 for 1 powder for injection.

How much does Kimyrsa cost with insurance?

Your individual healthcare plan will determine the copay of Kimyrsa with insurance. To find out what you will need to pay, contact your pharmacist or insurance provider. They will be able to calculate your copay with your current insurance.

What is Kimyrsa?

Kimyrsa is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Melinta Therapeutics, LLC. FDA approval of Kimyrsa was based on data from the phase 3 SOLO I clinical trials which compared a single dose of oritavancin 1200mg intravenously to vancomycin (1g or 15mg/kg twice daily intravenously for 7 to 10 days). Findings showed that oritavancin was as effective as vancomycin for primary and secondary endpoints. Approval was also based on data from an open-label pharmacokinetic study that compared Kimyrsa to Orbactiv given over 3 hours for the treatment of adults with ABSSSI.

KIMYRSA is a lipoglycopeptide antibiotic indicated for the treatment of adult patients with acute bacterial skin infections and skin structure infections (ABSSSI) caused by susceptible isolates of designated Gram-positive microorganisms. (Staphylococcus aureus (including methicillin-susceptible [MSSA] and methicillin-resistant [MRSA] isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus anginosus and Enterococcus faecalis (vancomycin-susceptible isolates only).

What doses of Kimyrsa are available?

Kimyrsa is available in injection form, in the following doses: 1,200 mg of lyophilized powder in a single-dose vial for reconstitution.

The two oritavancin products (Kimyrsa and Orbactiv) have differences in dose, strength, duration of infusion, and preparation, including reconstitution and dilution instructions and compatible diluents.m Administer 1,200 mg of Kimyrsa as a single dose by intravenous infusion over 1 hour.

Please read the full prescribing information and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.

Kimyrsa active ingredients

Kimyrsa contains oritavancin as the active ingredient.

Kimyrsa side effects

The most common adverse reactions of Kimyrsa in clinical trials include:

• Headache, nausea, vomiting
• Limb and subcutaneous abscesses, and diarrhea
• Hypersensitivity
• Pruritus
• Chills and pyrexia

In rare instances, Kimyrsa can cause more serious adverse effects. These can include:

• Coagulation test interference
• Serious hypersensitivity reactions, including anaphylaxis, have been reported with the use of oritavancin products. Monitor patients with known hypersensitivity to glycopeptides
• Infusion-related reactions
• Clostridioides difficile-associated diarrhea
• Osteomyelitis

Your doctor will assess the benefits of using Kimyrsa against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Kimyrsa to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Kimyrsa drug interactions

Other drugs may interact with Kimyrsa, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medication including any supplements you are taking.

Kimyrsa contraindications

You should not use Kimyrsa if you:

• Are allergic to the active ingredient oritavancin
• Are allergic to any of the other ingredients in Kimyrsa
• Have used intravenous unfractionated heparin sodium recently

Talk to your doctor before using Kimyrsa if you:

• Are taking any of the medications that could interact with Kimyrsa
• Have had an allergic reaction to medicines such as dalbavancin, telavancin, or vancomycin
• Use a blood thinner and have routine INR or prothrombin time tests
• Have recently been given a live bacterial vaccine
• Are pregnant or are planning to become pregnant
• Are breastfeeding or are planning to breastfeed

Kimyrsa generic

Kimyrsa is the trademark brand name for oritavancin manufactured by Melinta Therapeutics, LLC. A generic version of oritavancin is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Kimyrsa savings through NiceRx.

Related medications

• Orbactiv